Journals / Dicle Tıp Dergisi / 2016 / Cilt: 43 - Sayı: 2

Evaluation of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Rheumatoid Arthritis

Romatoid Artritte Nötrofil/ Lenfosit ve Platelet/ Lenfosit Oranlarının Değerlendirilmesi

Pages
241–247
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our opinion, larger studies consisting larger group will help determination of disease activity of RA by more specific indices using these parameters

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study is to investigate the relationship of disease activity with Neutrophil-Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) and red blood cell distribution width (RDW).
📊
Key Findings & Data:Methods: Seventy seven RA patients and 97 healthy subjects were examined retrospectively.
💡
Conclusion & Impact:In our opinion, larger studies consisting larger group will help determination of disease activity of RA by more specific indices using these parameters
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study is to investigate the relationship of disease activity with Neutrophil-Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) and red blood cell distribution width (RDW). Methods: Seventy seven RA patients and 97 healthy subjects were examined retrospectively. People with chronic and systemic diseases were excluded from control group of the study. The disease activity scores (DAS 28) of patient group, hematologic parameters and inflammation parameters of both groups were analyzed statistically using independent t-test and spearman correlation test.Results: Age and gender was not found different between groups. CRP and ESR levels were significantly higher in RA group (p<0.001). Hemoglobin and platelet count were lower (p<0.001 and p=0.022), while RDW, NLR, PLR and MPV levels were significantly higher in RA group (p<0.001, p<0.001. p<0.001, p<0.001, respectively). In patient group, ESR (p<0.001), lymphocytes (%) (p= 0.042), absolute neutrophil (p=0.047), and platelets (p= 0.019) were positively, whereas lymphocytes were negatively affected by improvement disease activity (DAS 28) scores. PLR levels significantly negatively correlated with MPV levels (r= -0.386) but showed a significant positive correlation with RDW (r= 0.354) and NLR levels (r= 0.618).Conclusion: NLR and PLR are important and promising factors for disease activity estimation of rheumatoid arthritis and may be used in clinical practice. In our opinion, larger studies consisting larger group will help determination of disease activity of RA by more specific indices using these parameters

Özet

Amaç: Bu çalışmanın amacı, romatoid artrit (RA), hastalık aktivitesi ile hematolojik parametrelerden nötrofil-lenfosit oranı (NLO), platelet lenfosit oranı (PLO) ve eritrosit dağılım genişliği (RDW) arasındaki ilişkiyi incelemektir.Yöntemler: Yetmiş yedi romatoid artrit hastası ve 97 sağlıklı bireyden oluşmuş kontrol grubu bu retrospektif çalışmaya dâhil edildi. Kontrol grubuna sistemik ve kronik herhangi bir hastalığı olan kişiler dâhil edilmedi. Hastaların hastalık aktivite skorları (DAS 28) ve her iki grubun hematolojik parametreleri ve inflamasyon parametreleri istatistiksel olarak Student-t testi ve Spearman korelasyon testiyle karşılaştırıldı.Bulgular: Yaş ve cinsiyet açısından gruplar arasında fark yoktu. C-reaktif protein (CRP) ve eritrosit sedimentasyon hızı (ESH) seviyeleri RA hasta grubunda anlamlı olarak yüksekti (p<0,001). RA hasta grubunda hemoglobin ve ortalama platelet hacmi (MPV) düzeyleri anlamlı olarak düşük bulunurken (sırasıyla; p<0,001, p=0,022) , trombosit, RDW, NLO ve PLO ise anlamlı olarak yüksek bulundu (sırasıyla; p<0.001, p<0.001, p<0,001, p<0,001). Hasta grubunda farklı hastalık aktivitesi seviyelerinde (DAS 28) ESH (p<0,001), mutlak nötrofil (p=0,04), trombosit (p=0,019) seviyeleri anlamlı olarak yüksekken, lenfosit (%) (p=0.042) seviyeleri anlamlı olarak düşüktü. PLO düzeyleri ile MPV düzeyleri (r=-0,386) negatif anlamlı korelasyon gösterirken, RDW seviyeleri (r=0,354) ve NLO düzeyleri (r=0,618) ile anlamlı pozitif korelasyon göstermekteydi.Sonuç: Romatoid artrit hastalık aktivitesinin değerlendirilmesinde NLO ve PLO doğru sonuçlar verirken, klinik pratikte kullanışlı bir parametre olabilirler. Geniş katılımlı çalışmalarla bu parametreler ile hastalık şiddetinin belirlenmesinde daha özgül endeksler geliştirilebilir

🔖

Cite This Article

KILIÇ, E., REZVANİ, A., TOPRAK, A. E., ERMAN, H., AYHAN, S. K., POYRAZ, E., ÖZARAS, N. (2016). Evaluation of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Rheumatoid Arthritis. Dicle Tıp Dergisi, Cilt: 43 - Sayı: 2, 241–247. https://ajindex.com/articles/205932

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376: 1094-1108
  2. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907- 916
  3. Karimifar M, Salesi M, Farajzadegan Z. The association of anti-CCP1 antibodies with disease activity score 28 (DAS- 28) in rheumatoid arthritis. Adv Biomed Res 2012;1:30
  4. Kay J, Morgacheva O, Messing SP, et al. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Res Ther 2014;16:R40
  5. Bowman SJ. Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 2002;31:251-259. 6. van Riel PL. The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol 2014;32:65-74
  6. Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628-632
  7. Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013;108:901-907
  8. Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653-657. 10. de Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010;14:192
  9. Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014;23:1204-1212
  10. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161
  11. Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009;31:277-297
  12. Colglazier CL, Sutej PG. Laboratory testing in the rheumatic diseases: a practical review. South Med J 2005;98:185- 191
  13. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448- 454
  14. Kapci M, Turkdogan KA, Duman A, et.al. Biomark